HER2-enriched subtype and pathological complete response in HER2-positive breast cancer: A systematic review and meta-analysis
Francesco Schettini(Breast Cancer Research Foundation), Tomás Pascual(Breast Cancer Research Foundation), Benedetta Conte(Ospedale Policlinico San Martino), Núria Chic(Breast Cancer Research Foundation), Fara Brasó‐Maristany(Breast Cancer Research Foundation), Patricia Galván, Olga Martínez‐Sáez(Breast Cancer Research Foundation), Bárbara Adamo(Breast Cancer Research Foundation), María Vidal(Breast Cancer Research Foundation), Montserrat Muñoz-Mateu(Breast Cancer Research Foundation), Aranzazu Fernández-Martínez(University of North Carolina at Chapel Hill), Carla Rognoni(Bocconi University), Gaia Griguolo(University of Padua), Valentina Guarneri(University of Padua), Pierfranco Conté(University of Padua), Mariavittoria Locci(University of Naples Federico II), Jan C. Brase(Novartis (Switzerland)), Blanca González‐Farré(Hospital Clínic de Barcelona), Patricia Villagrasa, Sabino De Placido(University of Naples Federico II), Rachel Schiff(Baylor College of Medicine), Jamunarani Veeraraghavan(Baylor College of Medicine), Mothaffar F. Rimawi(Baylor College of Medicine), C. Kent Osborne(Baylor College of Medicine), Sònia Pernas(Institut d'Investigació Biomédica de Bellvitge), Charles M. Perou(University of North Carolina at Chapel Hill), Lisa A. Carey(University of North Carolina at Chapel Hill), Aleix Prat(Breast Cancer Research Foundation)
Cited by 182Open Access